focus -WSS

focus

author：hotspot 2025-10-04 04:00:52 - browse：928

Jacob S. Van Naarden (left), Athena Countouriotis( center), and Vlad Coric (right) on stage at the 2023 STAT Summit. — From left, Eli Lilly's Jacob S. Van Naarden, Avenzo's Athena Countouriotis, and Biohaven's Vlad Coric on stage at the 2023 STAT Summit. STAT

What does it feel like to run a biotech startup and then get “the call” — the one from the big pharma CEO who wants to acquire your company for billions of dollars?

At the 2023 STAT Summit on Wednesday, senior biotech writer Adam Feuerstein posed this question to three people very qualified to answer it: Vlad Coric, chairman and CEO of Biohaven, which was acquired by Pfizer in 2022 for $11.6 billion; Jacob Van Naarden, former COO of Loxo Oncology, which was acquired by Eli Lilly (where Van Naarden is now executive vice president) for $8 billion in 2019; and Athena Countouriotis, whose company Turning Point Therapeutics was acquired by BMS for $4 billion in 2022.

“Imagine you’re going through your typical day, and you get a message: Albert Bourla, chairman and CEO of Pfizer, wants to talk at six o’clock tonight,” said Coric, whose company had a successful migraine drug on the market and had just completed an IPO at the time.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Why do we get seasonal allergies?

leisure time

WSS

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Why do we get seasonal allergies?

Illumina to lay off 10% of research and development team

The simple reason for the increase in autism diagnosis

Physician subsidies by hospitals soar in wake of No Surprises Act

focus

focus

entertainment

George Santos makes 1st court appearance after pleading not guilty to 13 counts

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

In Memoriam: Notable people who died in 2023

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

What does generative AI mean for health care? We asked experts

Traditional Chinese medicine benefits explored in new JAMA study

Drug repurposing or repositioning? The language matters

Readout Newsletter: XBI biotech index, Akero Therapeutics

The cancer drug shortage isn’t new — and neither are the solutions

The FDA weighs the risks of candy

leisure time

Readout Newsletter: XBI biotech index, Akero Therapeutics

Meta's Zuckerberg and Chan on track to put $50 billion into science

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Tuskegee Airman Raymond Cassagnol dies at 102

GOP hopefuls to address prominent, controversial group questioning what's taught in schools

CDC recommends rationing of RSV shot due to shortages

knowledge

focus

leisure time

explore